HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NeoStrata's NeoCeuticals

This article was originally published in The Rose Sheet

Executive Summary

Problem Dry Skin line, marketed by Glaxo Wellcome, is likely to hit shelves in the third or fourth quarter. The alpha hydroxy acid- containing line with glycolic and lactic acids became available through dermatologists and via a toll-free number in late 1997 ("The Rose Sheet" Dec. 1, 1997, p. 10). The products are targeted to consumers whose skin exhibits "unusual dryness, rough texture [or] extreme flaking and scaling" that does not respond to use of "conventional moisturizers," the company said...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS005294

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel